Work by Hsu et al. illustrated that platycodin D may help overcome resistance to HDAC inhibitors in HCC by inhibiting the Erk1/2-regulated phosphorylation of CFL-1, offering a potential therapeutic approach to circumvent chemotherapy resistance (Hsu et al., 2021). Here, HDAC9 is linked to hepatocellular carcinoma.